Department of Epidemiology and Community Health, School of Medicine, Virginia Commonwealth University, Richmond, Virginia 23298-0212, USA.
Am J Prev Med. 2010 May;38(5):499-507. doi: 10.1016/j.amepre.2010.01.020. Epub 2010 Mar 28.
Colorectal cancer (CRC) screening rates are suboptimal. The most important barriers identified by patients are poorly understood. A comprehensive assessment of barriers to all recommended modalities is needed.
In 2007, a questionnaire was mailed to 6100 patients, aged 50-75 years, from 12 family medicine practices in the Virginia Ambulatory Care Outcomes Research Network. People aged 65-75 years and African Americans were oversampled. Patients were asked to rate 19-21 barriers to each of four recommended tests. In 2008, responses were coded on a 5-point scale; higher scores reflected stronger barrier endorsement.
The response rate was 55% (n=3357). Approximately 40% of respondents were aged >/=65 years, 30% were African-American, and 73% were adherent to screening. A clinician's failure to suggest screening and not knowing testing was necessary received the highest mean scores as barriers. Financial concerns and misconceptions were also cited. Barrier scores differed depending on whether respondents were never screened, overdue for screening, or adherent to guidelines. The top five barriers for each modality included test-specific barriers (e.g., handling stool, bowel preparation), which often outranked generic barriers to screening. Not knowing testing was necessary was a top barrier for all tests but colonoscopy.
Although physician advice and awareness of the need for screening are important, barriers to screening are not homogenous across tests, and test-specific barriers warrant consideration in designing strategies to improve screening rates. Barrier scores differ by screening status, highlighting the need to address prior screening experience. Evidence that patients are more familiar with colonoscopy than with other modalities suggests an opportunity to improve screening rates by educating patients about alternative tests.
结直肠癌(CRC)筛查率不理想。患者所识别的最重要的障碍仍不清楚。需要对所有推荐方法的障碍进行全面评估。
2007 年,弗吉尼亚州门诊护理结果研究网络的 12 个家庭医疗实践中的 6100 名年龄在 50-75 岁的患者邮寄了一份问卷。对年龄在 65-75 岁和非裔美国人进行了抽样调查。患者被要求对四种推荐的检测方法中的每一种方法的 19-21 种障碍进行评分。2008 年,对回复进行了 5 分制编码;较高的分数反映了更强的障碍认可。
回复率为 55%(n=3357)。约 40%的受访者年龄≥65 岁,30%是非裔美国人,73%的人坚持筛查。医生未能建议筛查以及不知道检查是必要的,这两个因素被认为是最大的障碍。经济问题和误解也被提及。障碍评分因受访者是否从未接受过筛查、是否已过筛查时间或是否遵循指南而有所不同。每种方法的前五大障碍都包括测试特定的障碍(例如,处理粪便,肠道准备),这些障碍通常高于筛查的一般障碍。不知道检查是必要的是所有测试的最大障碍,但不包括结肠镜检查。
尽管医生的建议和对筛查必要性的认识很重要,但筛查障碍在不同的测试中并不相同,因此在设计提高筛查率的策略时,需要考虑测试特定的障碍。筛查状态不同,障碍评分也不同,这突出了需要解决先前的筛查经验。患者对结肠镜检查比其他方法更熟悉的证据表明,通过教育患者了解替代测试,有机会提高筛查率。